Filing of Integrated Financials for the quarter and year ended 31st Mrch 2025
MKPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
M K Proteins Limited submitted its audited standalone financial results for Q4 and full year ended 31 March 2025, approved on 23 May 2025. Revenue from operations for FY25 stood at Rs. 26,770.60 lakhs versus Rs. 24,557.11 lakhs in FY24, a modest ~9% rise. However, profit before tax fell sharply to Rs. 1,145.10 lakhs (from Rs. 1,546.97 lakhs) and PAT dropped to Rs. 839.74 lakhs from Rs. 1,121.19 lakhs, a decline of about 25%. Q4 PAT also halved to Rs. 279.61 lakhs (vs Rs. 582.98 lakhs). Statutory auditor KRA & Co. issued an unmodified (clean) opinion on the results. The company is engaged in a single segment — manufacturing of vegetable refined oil.
Despite steady revenue growth, profitability took a hit with PAT falling roughly 25% for the year, suggesting margin pressure from higher input costs. Clean auditor opinion is reassuring, but the sharp earnings dip may weigh on the stock in the short term.